MENU
IMMX
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

Immix Biopharma (IMMX) Ownership - Who owns Immix Biopharma?

Immix Biopharma Inc is engaged in the discovery and development of novel cell therapies for hematologic malignancies (blood cancers) and other indications... Show more

Profile

Industry
N/A
Address
11400 West Olympic Boulevard
Phone
+1 310 651-8041
Employees
17
Web
https://www.immixbio.com

Details

Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
239.36M
P/E Ratio
N/A
Total Cash
15.95M
Projected Growth
N/A
Total Debt
1.11M
Revenue
N/A
Risk (Beta)
-0.47
Dividend Yield
N/A
Total Cash/Share
0.30
Total Debt/Equity
N/A
Revenue/Share
null USD as % of share price

Fundamentals

IMMX
Capitalization
239M
P/E Ratio
N/A
Risk (Beta)
-0.47
Dividend Yield
N/A
Total Cash
15.9M
Total Cash/Share
0.30
Total Debt
1.11M
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0%
Revenue
0
ROE
N/A
Book Value
8.27M
P/B Ratio
28.99
Cash Flow
N/A
Earnings
-0.77
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
3.31K
Current Ratio
1.53
Current Revenue Per Employee
N/A
Dividends Per Share - Security
N/A
EBITDA
-23.74M
Float
N/A
Float - Current
N/A
Gross Income Margin
N/A
Revenue To Assets
-104.21
Shares Held By Institutions
8.04M
Shares Outstanding - Current
53M
Total Liabilities
11.8M
Total Volume MTD
N/A
Value
-1
Gain YTD
-13.576
View a ticker or compare two or three
IMMX
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. IMMX showed earnings on December 03, 2025. You can read more about the earnings report here.
A.I. Advisor
published General Information

General Information

Industry Biotechnology

Profile
Fundamentals
Details
Industry
N/A
Address
11400 West Olympic Boulevard
Phone
+1 310 651-8041
Employees
17
Web
https://www.immixbio.com